In one large clinical trial sponsored by Novo Nordisk, 1,961 adults with excess weight or obesity who did not have diabetes were given 2.4 milligrams of semaglutide or a placebo once a week for 68 weeks, along with lifestyle intervention. Those who took semaglutide lost 14.9% of their body weight compared with 2.4% for those who took the placebo.
https://www.forbes.com/health/body/ozempic-for-weight-loss/
So for a 150kg person, 15% weight loss makes them a 128kg person - still obese after 68 weeks. And ive read the injection is around $1000 per month ($12000 per year). Its not so effective to completely cure obesity, it just helps and an aid to weight loss. Its not going to have such a drastic effect on sleep apnea and other obesity related respiratory issues as the market is predicting (IMO).
In one large clinical trial sponsored by Novo Nordisk, 1,961...
Add RMD (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$30.98 |
Change
-0.170(0.55%) |
Mkt cap ! $19.67B | |||
| Open | High | Low | Value | Volume |
| $31.09 | $31.20 | $30.97 | $22.15M | 713.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 7229 | $30.98 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $31.11 | 10041 | 3 |
View Market Depth
| Last trade - 16.10pm 04/06/2024 (20 minute delay) ? |
|
|||||
|
Last
$30.99 |
Change
-0.170 ( 0.38 %) |
||||
| Open | High | Low | Volume | ||
| $31.10 | $31.19 | $30.98 | 134043 | ||
| Last updated 15.59pm 04/06/2024 ? | |||||
| RMD (ASX) Chart |